require < required < requirement

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000068 (2012)	Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]	Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales
000091 (2012)	Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Interleukin-6 and cytochrome-P450, reason for concern?
000102 (2011)	Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]	Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000148 (2013)	L. Naumann [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Antizytokintherapie
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000189 (2013)	Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]	Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000203 (2011)	K. Krüger [Allemagne]	Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller Stand
000235 (2010)	Manjari Lahiri [Singapour] ; Gim-Gee Teng [Singapour]	A case of refractory adult‐onset Still’s disease treated with anakinra
000241 (2010)	Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]	Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000273 (2012)	T. Adizie ; D. Christidis ; C. Dharmapaliah ; F. Borg ; B. Dasgupta [Royaume-Uni]	Efficacy and tolerability of leflunomide in difficult‐to‐treat polymyalgia rheumatica and giant cell arteritis: a case series
000568 (2014)	Koji Chiba [Japon] ; Hiroyuki Yoshitsugu [États-Unis] ; Yuto Kyosaka [Japon] ; Satofumi Iida [Japon] ; Koichiro Yoneyama [Japon] ; Takahiko Tanigawa [Allemagne] ; Takashi Fukushima [Japon] ; Masaki Hiraoka [Japon]	A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?
000683 (2013)	David Jayne [Royaume-Uni]	New-generation therapy for ANCA-associated vasculitis
000882 (2012)	Honghui Zhou [États-Unis] ; Yuko Tsukamoto [Japon] ; Hugh M. Davis [États-Unis]	Should Clinical Pharmacokinetic Bridging Studies Between Caucasian and Asian Populations Be Required for Approval of Monoclonal Antibodies?
000A41 (2008)	S. Elitok [Allemagne] ; R. Kettritz [Allemagne]	Pathogenese und Diagnostik von AA-Amyloidosen
000A43 (2013)	M. Aringer [Allemagne] ; T. Dörner [Allemagne]	Biosimilars
000A66 (2011)	Adriana R. Fonseca [Brésil] ; Sheila K. F. De Oliveira [Brésil] ; Marta C. F. Rodrigues [Brésil] ; Ierecê L. Aymoré [Brésil] ; Romeu C. Domingues [Brésil] ; Flavio R. Sztajnbok [Brésil]	Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review
000B05 (2012)	T. Magnus [Allemagne] ; A. Melms [Allemagne] ; I. Kötter [Allemagne] ; J. U. Holle [Allemagne]	Neurologische Manifestationen von Vaskulitiden und primäre ZNS-Vaskulitis
000C86 (2013)	Goohyeon Hong [Corée du Sud] ; Hojoong Kim [Corée du Sud, États-Unis]	Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement
000D68 (2013)	L. Yang [Japon] ; S. Serada [Japon] ; M. Fujimoto [Japon] ; H. Murota ; Y. Kotobuki [Japon] ; S. Kitaba ; T. Naka [Japon] ; I. Katayama	OP0230 Periostin, a novel matricellular protein, is required for cutaneous sclerosis in a mouse model of scleroderma
000F35 (2011)	Steven Gabardi [États-Unis]	Understanding Risk Evaluation and Mitigation Strategies in Organ Transplantation

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "required" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "required" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    required
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021